We've found
2,310
archived clinical trials in
Allergy
We've found
2,310
archived clinical trials in
Allergy
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Click here to add this to my saved trials
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Click here to add this to my saved trials
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Click here to add this to my saved trials
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Click here to add this to my saved trials
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Click here to add this to my saved trials
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Updated: 1/18/2017
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 1/18/2017
Click here to add this to my saved trials
Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis
Updated: 1/23/2017
A Randomized, Double-Blinded, Placebo-Controlled, Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of XmAb®7195
Status: Enrolling
Updated: 1/23/2017
Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis
Updated: 1/23/2017
A Randomized, Double-Blinded, Placebo-Controlled, Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of XmAb®7195
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
Trichuris Suis Ova in Peanut and Tree Nut Allergy
Updated: 2/2/2017
Trichuris Suis Ova Therapy for Mild to Moderate Peanut and Tree Nut Allergy in Adults and Children
Status: Enrolling
Updated: 2/2/2017
Trichuris Suis Ova in Peanut and Tree Nut Allergy
Updated: 2/2/2017
Trichuris Suis Ova Therapy for Mild to Moderate Peanut and Tree Nut Allergy in Adults and Children
Status: Enrolling
Updated: 2/2/2017
Click here to add this to my saved trials
A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
Updated: 3/2/2017
A Pre-season, Single Site, Single-blind, Parallel Group, Randomized Study to Determine the Tolerability and Safety of Two New Cumulative Doses of Modified Grass Allergens Adsorbed to L-tyrosine With Monophosphoryl Lipid A Adjuvant (Corixa), Phenol Preserved (Grass MATA MPL); Allergy Therapeutics, (UK) Ltd., Compared With Placebo in Patients With Seasonal Allergic Rhinoconjunctivitis Due to Grass Pollen Allergy.
Status: Enrolling
Updated: 3/2/2017
A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
Updated: 3/2/2017
A Pre-season, Single Site, Single-blind, Parallel Group, Randomized Study to Determine the Tolerability and Safety of Two New Cumulative Doses of Modified Grass Allergens Adsorbed to L-tyrosine With Monophosphoryl Lipid A Adjuvant (Corixa), Phenol Preserved (Grass MATA MPL); Allergy Therapeutics, (UK) Ltd., Compared With Placebo in Patients With Seasonal Allergic Rhinoconjunctivitis Due to Grass Pollen Allergy.
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
Updated: 3/2/2017
A Pre-season, Single Site, Single-blind, Parallel Group, Randomized Study to Determine the Tolerability and Safety of Two New Cumulative Doses of Modified Grass Allergens Adsorbed to L-tyrosine With Monophosphoryl Lipid A Adjuvant (Corixa), Phenol Preserved (Grass MATA MPL); Allergy Therapeutics, (UK) Ltd., Compared With Placebo in Patients With Seasonal Allergic Rhinoconjunctivitis Due to Grass Pollen Allergy.
Status: Enrolling
Updated: 3/2/2017
A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
Updated: 3/2/2017
A Pre-season, Single Site, Single-blind, Parallel Group, Randomized Study to Determine the Tolerability and Safety of Two New Cumulative Doses of Modified Grass Allergens Adsorbed to L-tyrosine With Monophosphoryl Lipid A Adjuvant (Corixa), Phenol Preserved (Grass MATA MPL); Allergy Therapeutics, (UK) Ltd., Compared With Placebo in Patients With Seasonal Allergic Rhinoconjunctivitis Due to Grass Pollen Allergy.
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
Reactions to Contrast Media (CM) Administered at the Time of the Endoscopic Retrograde Cholangiopancreatography (ERCP)
Updated: 3/15/2017
Reactions to Contrast Media (CM) Administered at the Time of Endoscopic Retrograde Cholangiopancreatography (ERCP)
Status: Enrolling
Updated: 3/15/2017
Reactions to Contrast Media (CM) Administered at the Time of the Endoscopic Retrograde Cholangiopancreatography (ERCP)
Updated: 3/15/2017
Reactions to Contrast Media (CM) Administered at the Time of Endoscopic Retrograde Cholangiopancreatography (ERCP)
Status: Enrolling
Updated: 3/15/2017
Click here to add this to my saved trials
Mouse Allergen and Asthma Intervention Trial
Updated: 3/15/2017
Mouse Allergen and Asthma Intervention Trial
Status: Enrolling
Updated: 3/15/2017
Mouse Allergen and Asthma Intervention Trial
Updated: 3/15/2017
Mouse Allergen and Asthma Intervention Trial
Status: Enrolling
Updated: 3/15/2017
Click here to add this to my saved trials
Mouse Allergen and Asthma Intervention Trial
Updated: 3/15/2017
Mouse Allergen and Asthma Intervention Trial
Status: Enrolling
Updated: 3/15/2017
Mouse Allergen and Asthma Intervention Trial
Updated: 3/15/2017
Mouse Allergen and Asthma Intervention Trial
Status: Enrolling
Updated: 3/15/2017
Click here to add this to my saved trials
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Lek Pharmaceuticals) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 3/27/2017
A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Fluticasone Furoate Nasal Spray (Lek Pharmaceuticals) With Veramyst® Nasal Spray (GlaxoSmithKline) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
Evaluating for Contact Allergies in Patients With Chronic Urticaria
Updated: 5/11/2017
Contact Allergens Causing Chronic Urticaria in a New England-Area Population
Status: Enrolling
Updated: 5/11/2017
Evaluating for Contact Allergies in Patients With Chronic Urticaria
Updated: 5/11/2017
Contact Allergens Causing Chronic Urticaria in a New England-Area Population
Status: Enrolling
Updated: 5/11/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Formula for Children With Cow's Milk Allergy
Updated: 6/7/2017
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents
Updated: 7/18/2017
The Optimal Dose of Prophylactic Naloxone in Ameliorating Opioid Induced Side Effects in Children and Adolescents Receiving Intravenous Patient Controlled Analgesia (IVPCA) Morphine for Moderate to Severe Pain: A Pharmacodynamic, Pharmacokinetic, and Pharmacogenetic Study
Status: Enrolling
Updated: 7/18/2017
Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents
Updated: 7/18/2017
The Optimal Dose of Prophylactic Naloxone in Ameliorating Opioid Induced Side Effects in Children and Adolescents Receiving Intravenous Patient Controlled Analgesia (IVPCA) Morphine for Moderate to Severe Pain: A Pharmacodynamic, Pharmacokinetic, and Pharmacogenetic Study
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Click here to add this to my saved trials
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Click here to add this to my saved trials
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Click here to add this to my saved trials
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Click here to add this to my saved trials
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Updated: 7/31/2017
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
Status: Enrolling
Updated: 7/31/2017
Click here to add this to my saved trials